Delivery Order SPE2DB22D3301-SPE2DB24FY4LP
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply RabAvert rabies vaccine with diluents. The contract, valued at $24,552.90, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division for the provision of RabAvert rabies vaccine with diluents. The $2,062.37 firm-fixed-price contract has a period of performance through May 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $3,860.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,497.82 to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, a $1,930.30 firm fixed price delivery order contract to provide RABAVERT rabies vaccine with diluents. This delivery order is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp. with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $9,651.50 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,895.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $2,895.45 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide RabAvert rabies vaccines and associated diluents. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit organization, a firm fixed price delivery order contract valued at $11,581.80 to provide RABAVERT rabies vaccine with diluents. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4LPDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, to supply RabAvert rabies vaccine with diluents. The contract has a ceiling value of $11,581.80 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this specific delivery order or the broader IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 4/11/24 |